Table 1.

Baseline demographic and clinical characteristics of patients.

	Group A (N = 43)	Group B (N = 160)	P-value
Age, years			0.91
Median (range)	51 (28, 71)	51 (19, 72)
Mean ± SD	50.35 ± 9.71	50.56 ± 10.98
Gender—n (%)			0.51
Male	37 (86.0)	128 (80.0)
Female	6 (14.0)	32 (20.0)
Liver donor—n (%)			0.71
Donors after circulatory death (DCD)	11 (25.6)	47 (29.4)
Donors after brain death (DBD)	32 (74.4)	113 (70.6)
Primary disease—n (%)			0.21
Hepatocellular carcinoma	24 (55.8)	86 (53.8)
Liver failure	7 (16.3)	14 (8.8)
Liver cirrhosis	9 (20.9)	55 (34.4)
Hepatic echinococcosis	2 (4.7)	2 (1.3)
Caroli's disease	1 (2.3)	3 (1.9)
Portal venous thrombosis—n (%)			0.84
Yerdal I	6 (14.0)	31 (19.4)
Yerdel II	3 (7.0)	8 (5.0)
Yerdel III	0	2 (1.3)
Collateral or varicose veins—n (%)			0.37
Large spontaneous portosystemic shunts	4 (9.3)	11 (6.9)
Coronary vein	4 (9.3)	7 (44.4)
Splenorenal shunt	0	4 (2.5)